Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zn regulated GTPase metalloprotein activator 1D, pseudogene (ZNG1DP) is a human pseudogene derived from the CBWD (COBW domain-containing) family, specifically related to functional Zn-regulated GTPase metalloprotein activator 1 (ZNG1). In contrast to the functional gene, this pseudogene does not encode a functional protein, is non-coding, and has no established biological, therapeutic, or diagnostic relevance. It represents a genomic sequence homologous to functional Cobalamin synthetase W domain genes but is incapable of protein production due to loss of function[1][3][6]. The parent family (COBW/CBWD) is involved in zinc homeostasis and metallochaperone activities, but pseudogene variants like ZNG1DP have no direct role in these processes[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zn regulated GTPase metalloprotein activator 1D, pseudogene (ZNG1DP).